Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer (SYSUCC-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01112826
Recruitment Status : Completed
First Posted : April 28, 2010
Last Update Posted : September 11, 2017
Information provided by (Responsible Party):
Zhong-yu Yuan, Sun Yat-sen University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2016
  Study Completion Date : December 2016